Novel innovations for stabilizing the plasma proteome in whole blood samples provide researchers with more confidence in their protein analysis. To reduce the preanalytical variability, scientists can ...
The plasma proteome is a rich source of potential biomarkers for diseases, such as cancer and neurodegenerative disorders. To assess these proteins, scientists commonly draw whole blood samples into ...
Tasso, maker of at-home blood sample collection systems, is launching the next generation of its devices that aim to support patients enrolled in clinical trials and simplify their participation in ...
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly ...
Remote blood collection device maker YourBio Health is revamping its leadership team with the goal of broadening the reach of its push-button, sample-harvesting hardware across clinical trials and ...
SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric clinical-grade blood collection solutions, today announced it received CE Mark certification for its Tasso+™ device, a ...
The test, run on Abbott (ABT)'s portable i-STAT ® Alinity ® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), or concussion The test produces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback